AltMountain

First Eagle Value in Biotechnology Fund (QP), LP

New York, NY · CIK 1481559
Status: no Form D since Mar 2018. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

First Eagle Value in Biotechnology Fund (QP), LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Mar 13, 2018, the fund has sold $68,150,000 of interests to 65 investors since its first sale in Sep 2005. The minimum investment it accepts from an outside investor is $1,000,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include First Eagle Investment Management, LLC.

Performance

No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$68,150,000Cumulative sales reported on Form D
Investors
65
First sale
Sep 15, 2005
Minimum investment
$1,000,000
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
First Eagle Investment Management, LLC
Latest Form D
Mar 13, 2018

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌​⁠

Raise history

$68,150,000Mar 12, 2012: $48,450,000 raisedMar 12, 2014: $52,700,000 raisedMar 12, 2015: $52,700,000 raisedMar 14, 2016: $52,700,000 raisedMar 13, 2017: $68,150,000 raisedMar 13, 2018: $68,150,000 raisedMar 2012Mar 2018
FiledFilingTotal raisedInvestorsSource
Mar 13, 2018Form D/A (amendment)$68,150,00065SEC.gov ↗
Mar 13, 2017Form D/A (amendment)$68,150,00065SEC.gov ↗
Mar 14, 2016Form D/A (amendment)$52,700,00065SEC.gov ↗
Mar 12, 2015Form D/A (amendment)$52,700,00065SEC.gov ↗
Mar 12, 2014Form D/A (amendment)$52,700,00065SEC.gov ↗
Mar 12, 2012Form D/A (amendment)$48,450,00063SEC.gov ↗

6 Form D filings in the SEC's electronic records (2008 onward), the earliest on Mar 12, 2012. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Related vehicles with the same name (2)

VehicleTotal raisedInvestorsLatest Form D
First Eagle Value in Biotechnology Fund (QP), LP (this page)$68,150,00065Mar 13, 2018
FIRST EAGLE VALUE IN BIOTECHNOLOGY OFFSHORE FUND LTD$3,471,8981Sep 20, 2013

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.

Questions about First Eagle Value in Biotechnology Fund (QP), LP

What is the minimum investment for First Eagle Value in Biotechnology Fund (QP), LP?

According to its latest Form D, filed Mar 13, 2018, the minimum investment First Eagle Value in Biotechnology Fund (QP), LP accepts from an outside investor is $1,000,000.

Who can invest in First Eagle Value in Biotechnology Fund (QP), LP?

First Eagle Value in Biotechnology Fund (QP), LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has First Eagle Value in Biotechnology Fund (QP), LP raised?

First Eagle Value in Biotechnology Fund (QP), LP reports $68,150,000 sold from 65 investors on its Form D filed Mar 13, 2018. This is cumulative sales since the offering began, not current assets or performance.

Where is First Eagle Value in Biotechnology Fund (QP), LP based?

First Eagle Value in Biotechnology Fund (QP), LP is based in New York, New York.

When did First Eagle Value in Biotechnology Fund (QP), LP launch?

First Eagle Value in Biotechnology Fund (QP), LP reports its first sale in Sep 2005.

Size compared with every hedge fund

Raised more than 48% of the 2,525 hedge funds based in New York, and more than 51% of all 10,146 that report sales.

More hedge funds in New York

Similar-size hedge funds in New York

All hedge funds in New York